Pharmacological Treatment of Herpes Zoster and Factors Associated with Its Recurrence
Open Access
- 14 April 2023
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 12 (4) , 757
Abstract
The burden of herpes zoster disease is significant worldwide, with millions affected and an increasing incidence. Increased age and immunosuppression due to disease or drugs have been related to its recurrence. The aim of this work was to determine the pharmacological management of herpes zoster and identify factors associated with recurrence, representing a longitudinal retrospective study identifying the pharmacological management of patients with herpes zoster and the factors related to the first recurrence using a population database. Follow-up was carried out for up to 2 years, and descriptive analysis and Cox proportional hazards regression were performed. A total of 2978 patients with herpes zoster were identified, with a median age of 58.9 years and 65.2% being women. The treatment mainly involved acyclovir (98.3%), acetaminophen (36.0%), and non-steroidal anti-inflammatory drugs (33.9%). A total of 2.3% of patients had a first recurrence. Corticosteroids were used in a greater proportion for recurrence than for the initial herpes episode (18.8% vs. 9.8%, respectively). Being female (HR:2.68;95%CI:1.39–5.17), age ≥60 years (HR:1.74;95%CI:1.02–2.96), having liver cirrhosis (HR:7.10;95%CI:1.69–29.80), and having hypothyroidism (HR:1.99;95%CI:1.16–3.40) were associated with greater probability of a first recurrence. The vast majority of patients were managed with acyclovir, and the use of acetaminophen or non-steroidal anti-inflammatory drugs for pain management was frequent. Several conditions were found that increased the probability of presenting a first recurrence of herpes zoster, such as age over 60 years, being a woman, suffering from hypothyroidism, and liver cirrhosis.Keywords
This publication has 30 references indexed in Scilit:
- Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availabilityJournal of Infection, 2016
- No Increased Risk of Herpes Zoster Found in Cirrhotic Patients: A Nationwide Population-Based Study in TaiwanPLOS ONE, 2014
- Hospital Admissions for Herpes Zoster in Portugal Between 2000 and 2010Acta Medica Portuguesa, 2013
- Corticosteroids for preventing postherpetic neuralgia2013
- Chronic Medical Conditions as Risk Factors for Herpes ZosterMayo Clinic Proceedings, 2012
- Epidemiological characteristics and societal burden of varicella zoster virus in the NetherlandsBMC Infectious Diseases, 2012
- Patient perspective on herpes zoster and its complications: An observational prospective study in patients aged over 50 years in general practicePain, 2012
- Herpes Zoster Recurrences More Frequent Than Previously ReportedMayo Clinic Proceedings, 2011
- Do herpes zoster patients receive antivirals? A Dutch national survey in general practiceFamily Practice, 2005
- The Incidence of Herpes ZosterArchives of internal medicine (1960), 1995